Skip to main content
. Author manuscript; available in PMC: 2009 Feb 10.
Published in final edited form as: Neurology. 2008 May 13;70(20):1926–1932. doi: 10.1212/01.wnl.0000312280.44805.5d

Table 1.

Ganglionic AChR antibody in patients with dysautonomia and other disorders*

Diagnostic Group % seropositive
Autonomic disorders
Subacute AAG 50%
Paraneoplastic AAG 25%
Postural tachycardia syndrome 10 – 15%
Idiopathic gastrointestinal dysmotility 5 – 10%
Diabetic autonomic neuropathy < 10%
Multiple system atrophy (Shy-Drager) 0
Other disorders
Lambert-Eaton syndrome 5 –10%
Myasthenia gravis without thymoma 1–2%
Paraneoplastic disorders with thymoma 15 – 20%
Paraneoplastic disorders with SCLC 3 – 5 %
*

None of 150 healthy control subjects were seropositive for ganglionic AChR antibodies.